3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Multiple Myeloma
39
Lymphoma, Large B-Cell, Diffuse
38
Burkitt Lymphoma
34
Lymphoma
31
Leukemia, Myeloid, Acute
31
Lymphoma, Non-Hodgkin
29
Recurrence
27
Breast Neoplasms
27
Neoplasms
23
Lymphoma, B-Cell
23
Myelodysplastic Syndromes
22
Leukemia, Lymphocytic, Chronic, B-Cell
22
Lymphoma, Follicular
20
Hodgkin Disease
18
Triple Negative Breast Neoplasms
17
Melanoma
17
Leukemia
17
Ovarian Neoplasms
16
Hematologic Neoplasms
15
Neuroblastoma
14
Lymphoma, Mantle-Cell
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
12
Pancreatic Neoplasms
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Leukemia, Biphenotypic, Acute
11
Neoplasm Metastasis
10
Lymphoma, B-Cell, Marginal Zone
10
Leukemia, Myelomonocytic, Chronic
10
Sarcoma
9
Interventions
pembrolizumab
1
10-propargyl-10-deazaaminopterin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Subcutaneous panniculitis-like T-cell lymphoma
×
Cyclophosphamide
×
90 days
×
Clear all
No trials found.